Literature DB >> 21339228

microRNAs in rheumatoid arthritis: midget RNAs with a giant impact.

Jürgen Wittmann1, Hans-Martin Jäck.   

Abstract

MicroRNAs (miRNAs) are tiny, non-coding molecules that primarily modulate gene expression at the post-transcriptional level by predominantly hybridising to complementary sequences in the 3'-untranslated region of their corresponding mRNAs. Depending on the degree of Watson-Crick base pairing, a miRNA either accelerates the degradation of the corresponding transcript or restricts its translation. There is compelling evidence that miRNAs have crucial roles in controlling and modulating immunity, while dysregulation of miRNAs can lead to autoimmunity and promote tumourigenesis, making miRNA regulation a balancing act between immunity and tumourigenesis. Here, the focus is on the role of miRNAs during the establishment and sustainment of rheumatoid arthritis (RA), a systemic, inflammatory autoimmune disease with irreversible joint destruction. An overview of the known function of miRNAs in RA and what the future might hold for the use of these small RNA molecules in RA diagnosis and treatment is provided.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21339228     DOI: 10.1136/ard.2010.140152

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  21 in total

Review 1.  Nanotherapeutic approaches for the treatment of rheumatoid arthritis.

Authors:  Christine T N Pham
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2011-08-11

Review 2.  Nanomedicines for chronic non-infectious arthritis: the clinician's perspective.

Authors:  Israel Rubinstein; Guy L Weinberg
Journal:  Nanomedicine       Date:  2012-05-26       Impact factor: 5.307

Review 3.  [MicroRNAs in B-cells and T-cells as regulators of inflammation].

Authors:  J Wittmann; H-M Jäck; M-F Mashreghi
Journal:  Z Rheumatol       Date:  2011-08       Impact factor: 1.372

Review 4.  MicroRNAs in rheumatoid arthritis.

Authors:  Angela Ceribelli; Md A Nahid; Minoru Satoh; Edward K L Chan
Journal:  FEBS Lett       Date:  2011-05-14       Impact factor: 4.124

Review 5.  Liquid biopsies to guide therapeutic decisions in rheumatoid arthritis.

Authors:  Roxana Coras; Rekha Narasimhan; Monica Guma
Journal:  Transl Res       Date:  2018-07-19       Impact factor: 7.012

6.  Mutual interaction between BCL6 and microRNAs in T cell differentiation.

Authors:  Zhiyuan Wei; Weiwu Gao; Yuzhang Wu; Bing Ni; Yi Tian
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

Review 7.  Epigenetics in rheumatoid arthritis: a primer for rheumatologists.

Authors:  Nunzio Bottini; Gary S Firestein
Journal:  Curr Rheumatol Rep       Date:  2013-11       Impact factor: 4.592

8.  Potential role of human-specific genes, human-specific microRNAs and human-specific non-coding regulatory RNAs in the pathogenesis of systemic sclerosis and Sjögren's syndrome.

Authors:  Sergio A Jimenez; Sonsoles Piera-Velazquez
Journal:  Autoimmun Rev       Date:  2013-05-15       Impact factor: 9.754

9.  The core microprocessor component DiGeorge syndrome critical region 8 (DGCR8) is a nonspecific RNA-binding protein.

Authors:  Braden M Roth; Daniella Ishimaru; Mirko Hennig
Journal:  J Biol Chem       Date:  2013-07-26       Impact factor: 5.157

Review 10.  MicroRNAs in lupus.

Authors:  Hong Zan; Connie Tat; Paolo Casali
Journal:  Autoimmunity       Date:  2014-06       Impact factor: 2.815

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.